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Abstract
We report a case of a 81-year-old Caucasian man with colorectal carcinoma, treated by surgery in
1998, referred for palliative treatment of a refractory painful caused by osteolytic metastases of
2.5 cm in back-upper ilium spine. Plasma-mediated radiofrequency ablation was performed under
conscious sedation, using Fluoroscopic Computer Tomography guidance. After completing the
ablation phase of the procedure, a mixture of bone cement and Biotrace sterile barium sulfate was
injected into the ablated cavity.
Patient was evaluated by using the Brief Pain Inventory and considering pain interference with daily
living at day 1 and 3 and week 1, 2, 3, 4 by means of a telephone interview. A post-procedure
Computer Tomography scan was performed to examine the distribution of cement deposition few
minutes after the procedure. The plasma mediated RFA and cementoplasty were well tolerated by
the patient who did not develop any complication.
Introduction
Painmanagement in terminally ill patients withmetastases
involving bone can be challenging. Conventional
therapeutic options for pain control include: radiation
therapy (RT), chemotherapy, surgery and the use of
analgesic drugs [1].
Despite these measures, the quality of life for these
patients is often poor because of intolerable pain. There
are many reasons for failure of traditional therapies to
control pain: (a) radiation insensitivity of the neoplasm
or limitations of radiation dose to normal structures,
(b) poor therapeutic response or toxicity of the
chemotherapeutic agent, (c) contraindication of major
surgery in patients with advanced disease and poor
functional status and (d) intolerable analgesic-related
side effects that may develop increasing of analgesic
doses [2].
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Investigators have so explored several alternative strategies
for the treatment of painful metastatic disease; these
involve the use of percutaneous image-guided methods to
locate tissue ablative devices into focal metastatic lesions:
ethanol [3], laser-induced interstitial thermotherapy [4],
percutaneous radiofrequency ablation (RFA) [5], and,
most recently, cryoablation [6].
This study investigates clinical viability of a novel
technique for the treatment of painful bone metastases:
the plasma-mediated RFA assisted with cement injection.
The plasma-mediated RFA was choice instead of simple
RFA because: the exterior margin of the cortical bone was
interrupted and this may result in a leakage of cement in
the nearby tissues and because the non plasma-mediated
RFA sometimes can give a coagulative necrosis which
doesn’t permit a correct allocation of the cement inside the
cavity.
Case presentation
We present a case of 81-year-old Caucasian man with a
history of colorectal carcinoma treated by surgery in 1998
was referred for palliative treatment of a refractory painful,
osteolyticmetastasis of 2.5 cm in back-upper ileum spine, as
showed in the Computer Tomography (CT) scans per-
formed before the treatment (Figure 1).
Prior to treatment, patient was assessed by Brief Pain
Inventory (BPI), visual-analogue scale (VAS) and record-
ing the use of analgesic drugs.
Before the RFA, the daily therapy of our patient consisted
in the following analgesics: 60 mg of morphine, 20 mg of
ketorolac-tromethamine and 5 mg of haloperidol; further-
more, he used morphine, at most 30 mg/day, and para-
cetamol 500 mg, at most 2 g/day.
In the BPI, patient is asked to rate his worst pain in 24
hours, least pain in 24 hours, and average pain, with
allowed responses ranging from 0 to 10. Relief of pain
through the use of analgesic medications is scored on a
scale of 0% (no relief) to 100% (complete relief). Pain
interference with daily living is evaluate with questions
concerning general activity, mood, walking ability, normal
work, relations with other people, sleep, and enjoyment of
life, also on a 0-10 scale (0 = no interference, 10 =
completely interferes). The patient was asked to answer
these questions with respect to the lesion that was to be
treated.
Before RFA an imaging-guided biopsy was performed and
the frozen specimen sent to Anatomy Patology Laboratory
to obtain confirm of malignancy.
An informed written consent was obtained for the patient.
A complete blood count (platelet: 167.000/mm3) and
prothrombin time (INR: 1,06) were obtained within
24 hours of the procedures.
The patient was treated with prophylactic antibiotics
therapy consisted of cefazolin, 1 g, three days before
the procedure and repeated every 8 hours over a 72-hours
period. The sedation was done in according to
the principles of “monitored anaesthesia care” receiving:
propofol (90 mg), alfentanyl (0.5 mg) and midazolam
(3 mg). The patient received oxygen during the procedures
and continuous monitoring of heart rate, electrocardio-
graphic tracing, oxygen saturation, and respiratory rate
were obtained, and blood pressure was determined every
4 minutes. Patient skin entry site of the planned needle
puncture was anaesthetized with 2% carbocaine. The
procedure was performed under fluoro-CT guidance
(Aquilion 64/Toshiba/Tokyo/Japan) with the patient in
the prone position. Access to the ilium spine was gained by
using a 11 G bone marrow harvesting needle that was
placed in the back-upper iliac spine to made a biopsy. The
bipolar radio-frequency-based device (CAVITY; Arthro-
Care, Sunnivale, Calif, USA) was advanced into the
delivery port (harvesting needle or introducer kit) until
its tip protruded beyond the cannula tip. The needle tip
was placed with different orientations to obtain a cavity;
Figure 1. CT scan before the radiofrequency session. CT
scan acquired with the patient in a prone position shows an
osteolytic metastasis of 2.5 cm in the right back-upper ileum
spine (black arrows).
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ablation was ceased when a noticeable reduction in
tactical resistance was detected. When inserting the device
towards the anterior aspect of the ileum spine, the tissue
dissolution setting was used. A total of 4 passes were made
to complete the cavity; it was left in place while preparing
the bone cement for insertion. After completing the
ablation, a mixture of bone cement (Zimmer, Warsaw,
Ind, USA) and Biotrace sterile barium sulfate (Bryan,
Worburn, Mass, USA) was injected into the ablated cavity
under CT-fluoroscopic guidance. On average, 3 ml of bone
cement was found to be sufficient to fill the ablated lesion
in the back-upper ilium spine. A post-procedure CT scan
was performed to examine the distribution of cement
deposition few minutes after the procedure. Patient was
evaluated for severity of pain by using the BPI and
considering pain interference with daily living at day 1 and
3 and week 1, 2, 3, 4 by means of a telephone interview.
The needle was correctly deployed inside the lesion, and
the total ablation time was of about 10 minutes. The
procedure was considered efficacious and no operative or
post-operative complications were observed. The patient
experienced a decrease in worst pain over the course of the
follow-up period; on the bases of BPI, at day 1 is worst
pain had score of 4 in the least 24 hours and the
interference of pain with daily living had score of 5.
Further, before plasma-mediated RFA, morphine was
reduced to 15 mg/day; worst pain remained stable up to
week 1. Length of stay in the hospital was 3 days, included
the day of the treatment.
Discussion
Approximately 40% of patients with cancer develop
metastatic disease; of these patients, 50% have poorly
Figure 2 (A) & (B). CT scan during the procedure. The electrode device is deployed inside the metastatic lesion and directed
anteriorly through the malignant mass (A); after completing the ablation a mixture of bone cement and sterile barium sulfate was
injected into the ablated cavity (B).
Figure 3. CT scans after the treatment. CT scans shows the
distribution of cement inside the cavity created into the lesion.
Page 3 of 5
(page number not for citation purposes)
Cases Journal 2009, 2:8548 http://casesjournal.com/casesjournal/article/view/8548
controlled pain. Achieving adequate pain control is often
difficult, and quality of life for the patients is poor [2]. RT
is considered the standard care for management of painful
bony metastases [7]. Other therapies, including che-
motherapy, hormonal therapy, radiopharmaceuticals and
surgery, may be used in an attempt to provide palliative
pain relief. With these therapies pain relief, when achieved,
may not occur until 4-12 weeks after the initiation of the
treatment. When these methods are not possible or are not
effective, analgesic medications remain as the only current
alternative therapy [5].
Although RT is generally considered effective for metastatic
bone cancer, this therapy may be administered a single
dose; however, most RT schedules involve daily treatments
over 2-3 weeks.
The time required to derive maximal benefit following RT
for solitary and multiple metastases is usually 12-20
weeks, it confirms that the time to achieve a benefit from
RT may be more prolonged than the time achieve
symptom relief in patients treated with RFA [5].
Conventional palliative external beam RT for painful
metastases includes several different local and wide-field
methods [7]. Unfortunately in about 60% of patients,
this treatment is complicated by toxic effects, including
nausea, vomiting, and diarrhoea.
Chemotherapy, by reducing the cancer volume, usually
reduces pain in 20%-80% of patients.
A positive response often occurs within 2 weeks and can
last for several months. Unfortunately, patients develop
multidrug resistance, and recurrence of bone pain is
common. Toxic effects, especially because of myelosup-
pression, are also common with chemotherapy for bone
pain [8].
Up to 70% of patients with cancer report relief from bone
pain after hormonal therapy or after single or multiagent
chemotherapy [8]. However, hormonal therapy appears to
be effective only in patients with breast or prostate cancer.
Radiopharmaceuticals, which have known benefit in
patients with diffuse painful metastases involving bone,
are not considered standard of care for patients with
isolated, painful lesions.[4]
Surgery is usually reserved for patients with impending
fracture or with spinal cord compression [6]. Analgesic
medications are the first line of treatment for bone pain in
cancer [9]. The World Health Organization [9] recom-
mends a progressive 3-step approach starting with no
steroidal anti-inflammatory drugs such as aspirin,
ibuprofen, and naproxen to relieve mild to moderate
pain. If pain persists or increases, step 2 adds a weak
opioid such as codeine or hydrocodone. For persistent or
moderate to severe pain, step 3 calls for more potent or
higher doses of opioids such as morphine, hydromor-
phone, or fentanyl on a continuous or as-needed basis.
Their efficacy may be improved by the concurrent
administration of tricyclic antidepressants or phenothia-
zine. The use of many of these agents can be hindered by
their substantial side effects, which often complicate the
treatment of patients with cancer pain, including con-
stipation, limitations in physical and mental status [9].
RFA represent a valid and potential alternative method for
palliation of painful osteolytic metastases and many
publications confirmed that RFA is a safe and effective-
ness procedure in the treatment of localized, painful
osteolytic metastases involving bone [4,5]. The mechan-
ism of action responsible for decreased pain at the
metastatic site after RFA includes: (a) physical destruction
of adjacent sensory nerve fibres involving the periosteum
and cortex of bone, inhibiting pain transmission; (b)
mechanical decompression of cancer volume, decreasing
stimulation of sensory nerve fibres; (c) destruction of
tumour cells that produce nerve-stimulating cytokines
(TNFa, interleukins, and others), whichmay sensitize nerve
fibres and affect pain transmission; and (d) inhibition of
osteoclast activity, which may cause pain [10].
In addition with RFA, other Authors [11-13] proposed the
use of cementoplasty. The rational of this combined
therapy is the stabilization of microfractures and reduction
of mechanical forces, especially for larger tumours. In
Toyota et al. [11] using RFA combined with cementoplasty
for bulky tumours extending to extraosseus region obtain
an analgesic reduction in only 41% of patients; probably
the cause of this difference compared with RFA alone are
due to the fact tumours’ size were relatively larger in this
series. Percutaneous RFA and cement injection is widely
used to treat painful metastasis involving bone but have
relatively higher risk of complications. They are often
associated with epidural extensions or posterior cortical
disruption, witch may increase risk for leakage and
subsequent compromise of thecal sac during cement
delivery [11].
Schaefer et al [14] reported that RF heat ablationhas proved
to be an effective method for the treatment of skeletal
disease; because of the coagulation necrosis produced by
the RF heat ablation, a homogenous distribution of cement
in the lesion was possible [14].
Georgy et al [15] have demonstrated that dissolution of
tissue by plasma-mediated RFA rather than displacement
to create a cavity before injecting bone cement permitted
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well-directed cement deposition into the compromised
vertebral body, which may allow a safer procedure to be
conducted in patients with advanced malignant vertebral
compression fractures. Clinical benefits may include
avoiding more extensive surgery and reducing the risk of
complications associated with conventional bone cement
injection procedures.
A tissue cavity can be achieved using other means, such as
the kyphoplasty system. We believe that the advantage of
using plasma-mediated RF based technology is the ability
to create such a cavity using a tissue dissolution process, as
opposed to simply displacing it. Moreover this technique
provides the additional theoretic benefit of improving
interdigitation of the cement, which normally be blocked
by displaced tissue.
According with Georgy experience [15], we believe that
this new technique present the inability to visualize the
presumed cavity created by ablation; this was difficult to
see in the post-procedure CT-scan examinations for two
reasons. First because the cement was presumably
deposited at the site of the create void and second because
of the beam-hardening artefacts. The presence of gas in the
needle tract stemming from tissue dissolution or the
pattern of cement deposition inside the lytic lesion,
represent two important indirect indicators of the tissue
cavity created.
Conclusion
Although larger series are needed to confirm our data, our
experience suggest that plasma-mediated RFA assisted
with cement injection is a new and potentially efficacy
treatment for painful extra-vertebral bone metastases.
This technique may be safer than conventional cemento-
plasty of RFA associated to cementoplasty by providing a
space for bone cement placement and plasma-mediated
RFA could be more efficacious than non plasma-mediated
because it limits the cement leakage damage to the nearby
tissues.
Further clinical experience and prospective studies are
needed to determine the long-term efficacy of combined
RFA and percutaneous cementoplasty.
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